Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04261881 · ClinicalTrials.gov registry record · NA
Nutraceutical Support of Fatigue Reduction, Improved Physical, Mental & Cognitive Function and Mitochondrial Function
A NA study, sponsored by Natural Immune Systems.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT04261881 is a NA study that has completed, run by Natural Immune Systems. The registered enrollment target is 36 participants.
The verdict
NCT04261881, a NA study, has completed, sponsored by Natural Immune Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose for this protocol is to perform an open-label human clinical pilot study on the effects of consumption of two nutraceutical blends in subjects with long-term unexplained fatigue interfering with daily living.
Interventions
- DIETARY_SUPPLEMENT ATP-Fuel
- DIETARY_SUPPLEMENT ATP-II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2018-03-27 |
| Est. Completion | 2020-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04261881
The ClinicalTrials.gov registry entry for NCT04261881 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natural Immune Systems, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ATP-Fuel is the first listed.
NCT04261881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04261881 about?
NCT04261881 is a clinical study titled "Nutraceutical Support of Fatigue Reduction, Improved Physical, Mental & Cognitive Function and Mitochondrial Function". The purpose for this protocol is to perform an open-label human clinical pilot study on the effects of consumption of two nutraceutical blends in subjects with long-term unexplained fatigue interfering with daily living.
What is the current status of trial NCT04261881?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2018-03-27. Estimated completion is 2020-04-08.
What interventions are being tested in trial NCT04261881?
The interventions under investigation include: ATP-Fuel (DIETARY_SUPPLEMENT), ATP-II (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04261881?
This trial is sponsored by Natural Immune Systems, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.